Guideline recommendations for heart complications in thalassemia major

Area of Science:

• Cardiology
• Hematology
• Genetics

Background:

• Thalassemia major is an inherited blood disorder causing chronic hemolytic anemia and iron overload from transfusions.
• Iron overload leads to significant mortality and morbidity, with heart complications being the primary cause of death.
• Recent advances in chelation therapy have improved life expectancy by reducing cardiac mortality.

Purpose of the Study:

• To provide specific recommendations for managing heart complications in thalassemia major patients.
• To outline the definition, follow-up, and treatment strategies for cardiac issues in this population.
• To establish guidelines based on established cardiology standards.

Main Methods:

• Development of recommendations by the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).
• Collaboration with major Italian cardiology and radiology societies (ANMCO, SIC, SIRM).
• Adherence to American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, with external peer review.

Main Results:

• The recommendations cover the spectrum of heart damage in thalassemia major, including ventricular dysfunction, pulmonary hypertension, and arrhythmias.
• They provide a framework for consistent and effective patient management.
• The guidelines aim to standardize care and improve outcomes for patients with thalassemia major.

Conclusions:

• Specific recommendations are crucial for addressing the main heart complications in thalassemia major.
• These guidelines offer a standardized approach to the definition, follow-up, and treatment of cardiac issues.
• Implementation of these recommendations is expected to further improve the quality of life and survival rates for thalassemia major patients.